Your browser doesn't support javascript.
loading
Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.
Woods-Hill, Charlotte Z; Colantuoni, Elizabeth A; Koontz, Danielle W; Voskertchian, Annie; Xie, Anping; Thurm, Cary; Miller, Marlene R; Fackler, James C; Milstone, Aaron M; Agulnik, Asya; Albert, J Elaine-Marie; Auth, Michael J; Bradley, Erin; Clayton, Jason A; Coffin, Susan E; Dallefeld, Samantha; Ezetendu, Chidiebere P; Fainberg, Nina A; Flaherty, Brian F; Foster, Charles B; Hauger, Sarmistha B; Hong, Sue J; Hysmith, Nicholas D; Kirby, Aileen L; Kociolek, Larry K; Larsen, Gitte Y; Lin, John C; Linam, William M; Newland, Jason G; Nolt, Dawn; Priebe, Gregory P; Sandora, Thomas J; Schwenk, Hayden T; Smith, Craig M; Steffen, Katherine M; Tadphale, Sachin D; Toltzis, Philip; Wolf, Joshua; Zerr, Danielle M.
Afiliação
  • Woods-Hill CZ; Division of Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Colantuoni EA; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
  • Koontz DW; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
  • Voskertchian A; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Xie A; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Thurm C; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Miller MR; Armstrong Institute for Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Fackler JC; Children's Hospital Association, Lenexa, Kansas.
  • Milstone AM; Rainbow Babies and Children's Hospital, Cleveland, Ohio.
  • Agulnik A; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Albert JE; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Auth MJ; Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, Maryland.
  • Clayton JA; Department of Global Pediatric Medicine, Division of Critical Care, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Coffin SE; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle.
  • Dallefeld S; Division of Pediatric Critical Care, Department of Pediatrics, Dell Medical School, University of Texas at Austin.
  • Ezetendu CP; Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Fainberg NA; University Hospitals, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
  • Flaherty BF; Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Foster CB; Division of Pediatric Critical Care, Department of Pediatrics, Dell Medical School, University of Texas at Austin.
  • Hauger SB; Cleveland Clinic Children's Hospital, Cleveland, Ohio.
  • Hong SJ; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Hysmith ND; University of Utah, Department of Pediatrics, Division of Critical Care, Salt Lake City.
  • Kirby AL; Center for Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio.
  • Kociolek LK; Division of Pediatric Infectious Disease, Dell Medical School, University of Texas at Austin.
  • Larsen GY; Division of Critical Care, Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois.
  • Lin JC; Department of Pediatrics, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis.
  • Linam WM; Division of Pediatric Critical Care, Doernbecher Children's Hospital, Oregon Health & Science University, Portland.
  • Newland JG; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Nolt D; Division of Critical Care Medicine, Department of Pediatrics, Intermountain Primary Children's Hospital, University of Utah, Salt Lake City.
  • Priebe GP; Washington University School of Medicine, St Louis, Missouri.
  • Sandora TJ; Emory School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Schwenk HT; Washington University School of Medicine, St Louis, Missouri.
  • Smith CM; Doernbecher Children's Hospital, Oregon Health & Science University, Portland.
  • Steffen KM; Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Tadphale SD; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
  • Toltzis P; Department of Anesthesia, Harvard Medical School, Boston, Massachusetts.
  • Wolf J; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
  • Zerr DM; Stanford University School of Medicine, Lucile Packard Children's Hospital Stanford, Stanford, California.
JAMA Pediatr ; 176(7): 690-698, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35499841
ABSTRACT
Importance Blood culture overuse in the pediatric intensive care unit (PICU) can lead to unnecessary antibiotic use and contribute to antibiotic resistance. Optimizing blood culture practices through diagnostic stewardship may reduce unnecessary blood cultures and antibiotics.

Objective:

To evaluate the association of a 14-site multidisciplinary PICU blood culture collaborative with culture rates, antibiotic use, and patient outcomes. Design, Setting, and

Participants:

This prospective quality improvement (QI) collaborative involved 14 PICUs across the United States from 2017 to 2020 for the Bright STAR (Testing Stewardship for Antibiotic Reduction) collaborative. Data were collected from each participating PICU and from the Children's Hospital Association Pediatric Health Information System for prespecified primary and secondary outcomes. Exposures A local QI program focusing on blood culture practices in the PICU (facilitated by a larger QI collaborative). Main Outcomes and

Measures:

The primary outcome was blood culture rates (per 1000 patient-days/mo). Secondary outcomes included broad-spectrum antibiotic use (total days of therapy and new initiations of broad-spectrum antibiotics ≥3 days after PICU admission) and PICU rates of central line-associated bloodstream infection (CLABSI), Clostridioides difficile infection, mortality, readmission, length of stay, sepsis, and severe sepsis/septic shock.

Results:

Across the 14 PICUs, the blood culture rate was 149.4 per 1000 patient-days/mo preimplementation and 100.5 per 1000 patient-days/mo postimplementation, for a 33% relative reduction (95% CI, 26%-39%). Comparing the periods before and after implementation, the rate of broad-spectrum antibiotic use decreased from 506 days to 440 days per 1000 patient-days/mo, respectively, a 13% relative reduction (95% CI, 7%-19%). The broad-spectrum antibiotic initiation rate decreased from 58.1 to 53.6 initiations/1000 patient-days/mo, an 8% relative reduction (95% CI, 4%-11%). Rates of CLABSI decreased from 1.8 to 1.1 per 1000 central venous line days/mo, a 36% relative reduction (95% CI, 20%-49%). Mortality, length of stay, readmission, sepsis, and severe sepsis/septic shock were similar before and after implementation. Conclusions and Relevance Multidisciplinary diagnostic stewardship interventions can reduce blood culture and antibiotic use in the PICU. Future work will determine optimal strategies for wider-scale dissemination of diagnostic stewardship in this setting while monitoring patient safety and balancing measures.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Choque Séptico / Sepse Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: America do norte Idioma: En Revista: JAMA Pediatr Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Choque Séptico / Sepse Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: America do norte Idioma: En Revista: JAMA Pediatr Ano de publicação: 2022 Tipo de documento: Article